Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumor, Adult × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Unspecified Adult Solid Tumor, Protocol Specific 4 Sarcoma 4 Colorectal Neoplasms 4 Neoplasms 3 Neoplasm Metastasis 3 Colonic Neoplasms 3 Thymoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Myeloproliferative Disorders 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Melanoma 2 Leukemia, Myelomonocytic, Chronic 2 Esophageal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Thrombocythemia, Essential 1 Solid Tumor, Adult 1 Small Cell Lung Carcinoma 1 Sarcoma, Synovial 1 Recurrence 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Polycythemia Vera 1

Interventions

Cyclophosphamide 3 pembrolizumab 2 fludarabine 2 Radiotherapy 2 Paclitaxel 2 Ipilimumab 2 Interleukin-2 2 Carboplatin 2 spartalizumab 1 peposertib 1 niraparib 1 neotil 1 necitumumab 1 Valganciclovir 1 Tomography, X-Ray Computed 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 Docetaxel 1 Cetuximab 1 Celecoxib 1 CS-1003 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡